SCHEMBL6506895

SCHEMBL6506895

CCCCc1cccc(C(=O)N(C)OC)c1CO[SiH](C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 3/20 0.35
ALOX5 P09917 1/20 0.33
PTGS2 P35354 1/20 0.33
BID P55957 3/20 0.32
MCL1 Q07820 3/20 0.32
BCL2L1 Q07817 2/20 0.32
BAK1 Q16611 2/20 0.32
KAT8 Q9H7Z6 2/20 0.32
PPARG P37231 2/20 0.32
EP300 Q09472 1/20 0.32
KAT2A Q92830 1/20 0.32
KAT2B Q92831 1/20 0.32
KAT5 Q92993 1/20 0.32
SAE1 Q9UBE0 1/20 0.32
GABRA1 P14867 1/20 0.31
GABRB2 P47870 1/20 0.31
APLNR P35414 1/20 0.31
TSHR P16473 2/20 0.31
LTB4R Q15722 1/20 0.31
LTB4R2 Q9NPC1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8131350 0.74 CYP1A2 (0.36) PPARAALOX5PTGS2BIDMCL1
SCHEMBL13806872 0.69 ALDH1A1 (0.42) TSHRALDH1A1HSD17B10TP53
SCHEMBL5838970 0.69 ALDH1A1 (0.35) TDP1L3MBTL1ALDH1A1HSD17B10
SCHEMBL6506891 0.68 TSHR (0.38) TSHRTDP1L3MBTL1ALDH1A1TP53
SCHEMBL19094486 0.67 ALDH1A1 (0.49) PPARAALOX5PTGS2BIDMCL1
SCHEMBL28858812 0.66 TSHR (0.44) PPARAALOX5PTGS2BIDMCL1
SCHEMBL12418029 0.65 LMNA (0.55) TSHRTDP1L3MBTL1ALDH1A1TP53
SCHEMBL30577968 0.65 TRPM8 (0.36) TSHRALDH1A1
SCHEMBL169572 0.65 BID (0.50) PPARABIDMCL1BCL2L1BAK1
SCHEMBL12475592 0.65 BID (0.43) PPARAALOX5PTGS2BIDMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107448-A1 Calcium receptor antagonists JAPAN TABACCO INC. 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107448-A1 Calcium receptor antagonists CASR, CALCR, CALCRL PPARA 2900/4885ALOX5 1662/4885PTGS2 3243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.